Showing results (241-250 of 270) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2008
Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancerLisa K Dunnwald, Julie R Gralow, Georgiana K Ellis, et al.
Cancers|June 12, 2026
Deep Learning-Based Synthetic Contrast-Enhanced Breast MRI for Monitoring Response to Neoadjuvant TherapySuleeporn Sujichantararat, Debosmita Biswas, Anum S Kazerouni, et al.
Molecular Imaging and Biology|May 14, 2025
[18 F]-Fluoroestradiol PET (FES-PET) and [18 F] Flurodeoxyglucose PET (FDG-PET) Imaging May Aid in Managing Therapy in Patients with Metastatic Lobular Breast CancerPoorni M Manohar, Lanell M Peterson, Isaac C Jenkins, et al.
Radiology|May 18, 2021
Digital Mammography and Breast Tomosynthesis Performance in Women with a Personal History of Breast Cancer, 2007-2016Janie M Lee, Laura E Ichikawa, Karen J Wernli, et al.
Radiation Oncology (London, England)|June 11, 2014
Hsp70--a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neckMathias Gehrmann, Hanno M Specht, Christine Bayer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 12, 2018
Prospective Study of Serial 18F-FDG PET and 18F-Fluoride PET to Predict Time to Skeletal-Related Events, Time to Progression, and Survival in Patients with Bone-Dominant Metastatic Breast CancerLanell M Peterson, Janet O'Sullivan, Qian Vicky Wu, et al.
American Journal of Clinical Oncology|September 19, 2023
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) DatabaseBonny Chau, Elizabeth T Loggers, Lee D Cranmer, et al.
Breast Cancer Research : BCR|August 24, 2021
18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity studyPerrin E Romine, Lanell M Peterson, Brenda F Kurland, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 28, 2020
18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2- Metastatic Breast CancerLanell M Peterson, Brenda F Kurland, Fengting Yan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2011
Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancerHannah M Linden, Brenda F Kurland, Lanell M Peterson, et al.
Pageof 27